Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1
V Rakocevic Stojanovic1, S Peric, D Lavrnic
1Institute of Neurology, Clinical Center of Serbia, Belgrade, Serbia. vidosava_r@yahoo.co.uk
Objectives:
To evaluate serum leptin concentration and its relation to metabolic syndrome (MSy) in non-diabetic patients with myotonic dystrophy type 1 (DM1).
Materials And Methods:
This study included 34 DM1 patients, and the same number of healthy subjects matched for age, sex and body mass index (BMI).
Results:
DM1 patients had increased BMI and insulin resistance, and increased leptin and insulin concentrations, but the other features of MSy such as diabetes, glucose intolerance and hypertension were not detected in DM1 patients. Serum leptin levels were higher in patients with DM1 than in healthy controls (8.5 +/- 6.6 ng/ml vs 3.6 +/- 2.9 ng/ml in men, and 13.9 +/- 10.0 ng/ml vs 10.9 +/- 6.9 ng/ml in women, respectively). In DM1 patients, leptin levels correlated with BMI, fasting insulin and insulin resistance (HOMA) (P < 0.01).
Conclusions:
The leptin overproduction correlated with insulin resistance in DM1 patients but the significance of this finding remains unclear.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Type II Diabetes II: Pathophysiology
Alterations in Muscle Tone lll
Type II Diabetes I: Introduction
Inborn Errors of Metabolism
Lysosomal Hydrolases


